equol has been researched along with Anterior Cerebral Circulation Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, XL; Li, GR; Wang, Y; Yu, W; Zhao, LM; Zhou, DX | 1 |
1 other study(ies) available for equol and Anterior Cerebral Circulation Infarction
Article | Year |
---|---|
Equol is neuroprotective during focal cerebral ischemia and reperfusion that involves p-Src and gp91(phox).
Topics: Animals; Brain Infarction; Disease Models, Animal; Equol; Gene Expression Regulation; Glucose; Hypoxia; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Male; Malondialdehyde; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nervous System Diseases; Neuroprotective Agents; PC12 Cells; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); Rats; Rats, Sprague-Dawley; Reperfusion | 2014 |